Head-To-Head Survey: Tabula Rasa Healthcare (TRHC) and The Competition
Tabula Rasa Healthcare (NASDAQ: TRHC) is one of 18 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it weigh in compared to its peers? We will compare Tabula Rasa Healthcare to related companies based on the strength of its profitability, earnings, analyst recommendations, risk, dividends, valuation and institutional ownership.
Earnings & Valuation
This table compares Tabula Rasa Healthcare and its peers revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Tabula Rasa Healthcare||$108.83 million||$2.26 million||-37.45|
|Tabula Rasa Healthcare Competitors||$376.98 million||$34.79 million||8.32|
Tabula Rasa Healthcare’s peers have higher revenue and earnings than Tabula Rasa Healthcare. Tabula Rasa Healthcare is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This is a summary of recent ratings for Tabula Rasa Healthcare and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Tabula Rasa Healthcare||0||1||4||0||2.80|
|Tabula Rasa Healthcare Competitors||116||485||798||16||2.50|
Tabula Rasa Healthcare currently has a consensus price target of $21.00, indicating a potential downside of 24.22%. As a group, “Medical Software & Technology Services” companies have a potential upside of 19.30%. Given Tabula Rasa Healthcare’s peers higher probable upside, analysts clearly believe Tabula Rasa Healthcare has less favorable growth aspects than its peers.
Institutional & Insider Ownership
28.9% of Tabula Rasa Healthcare shares are held by institutional investors. Comparatively, 63.1% of shares of all “Medical Software & Technology Services” companies are held by institutional investors. 45.8% of Tabula Rasa Healthcare shares are held by company insiders. Comparatively, 21.9% of shares of all “Medical Software & Technology Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares Tabula Rasa Healthcare and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Tabula Rasa Healthcare||-10.27%||-9.58%||-4.51%|
|Tabula Rasa Healthcare Competitors||-18.14%||-11.85%||-2.19%|
Tabula Rasa Healthcare peers beat Tabula Rasa Healthcare on 6 of the 11 factors compared.
About Tabula Rasa Healthcare
Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.
Receive News & Stock Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related stocks with our FREE daily email newsletter.